BLUEPHARMA - INDUSTRIA FARMACEUTICASA -  

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 215.773 0 1
2016 0 4.993.834 327.671 1
2015 0 5.855.219 479.924 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
APTUIT1
ASSOCIACAO UNIVERSIDADE EMPRESA PARA DESENVOLVIMENTO TECMINHO1
BEYONDEVICES LDA1
BLUECLINICAL INVESTIGACAO E DESENVOLVIMENTO EM SAUDE LDA1
CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA EPE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CURVE CLINICAL BV1
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC1
LINICAL ACCELOVANCE EUROPE BV1
MEDIZINISCHE UNIVERSITAET WIEN1
NARODNY USTAV REUMATICKYCH CHOROBNURCH NIRD NATIONAL INSTITUTE OF RHEUMATIC DISEASES1
SOLFARCOS SOLUCOES FARMACEUTICAS E COSMETICAS LDA1
STICHTING TOOLS1
STICHTING VU1
STICHTING VUMC1
SYNOVO1
UNIVERSIDADE DE COIMBRA1
UNIVERSITA DEGLI STUDI DI GENOVA1
UNIVERSITAET FUER BODENKULTUR WIEN1
UNIVERSITATEA DE MEDICINA SI FARMACIE'CAROL DAVILA' DIN BUCURESTI1
UNIVERSITY OF DEBRECEN1

Constancy:

Total number of partners: 23
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 23
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Engineering the immunosuppressive microenvironment in mesothelioma with targeted LipidNanoParticles encapsulating self-amplifying RNA OncoNanoRparticipant215.7732
2016-01-01Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis FOLSMARTparticipant4.993.83411
2015-09-01Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis GLORIAparticipant5.855.21913